BRIEF published on 05/19/2025 at 19:21, 9 months ago EB Development dépasse les 90 % du capital d'Eurobio Scientific Diagnostic In Vitro Réunion Financière Eurobio Scientific Développement EB 90 % Des Actions
BRIEF published on 05/19/2025 at 19:21, 9 months ago EB Development Surpasses 90% Stake in Eurobio Scientific In Vitro Diagnostics Eurobio Scientific EB Development Financial Meeting 90% Shareholding
PRESS RELEASE published on 05/19/2025 at 19:16, 9 months ago Eurobio Scientific : EB Development franchit à la hausse le seuil de 90% EB Development franchit à la hausse le seuil de 90% du capital d'Eurobio Scientific suite à une acquisition d'actions sur le marché. Prochain rendez-vous financier : Assemblée générale le 19 juin 2025 Franchissement De Seuil Assemblée Générale Diagnostic Médical Eurobio Scientific EB Development
PRESS RELEASE published on 05/19/2025 at 19:16, 9 months ago Eurobio Scientific: EB Development rises above 90% threshold Eurobio Scientific's shareholder EB Development surpasses 90% share capital threshold through market acquisitions. Financial meeting: Annual General Meeting on June 19, 2025 Share Capital Eurobio Scientific EB Development Financial Meeting 90% Threshold
BRIEF published on 04/29/2025 at 21:05, 9 months 20 days ago Availability of the 2024 annual financial report by Eurobio Scientific Investors In Vitro Diagnostics General Meeting Annual Report 2024 Eurobio Scientific
BRIEF published on 04/29/2025 at 21:05, 9 months 20 days ago Mise à disposition du rapport financier annuel 2024 par Eurobio Scientific Diagnostic In Vitro Assemblée Générale Investisseurs Rapport Annuel 2024 Eurobio Scientific
PRESS RELEASE published on 04/29/2025 at 21:00, 9 months 20 days ago Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024 Eurobio Scientific annonce la mise à disposition de son rapport financier annuel 2024 auprès du public et de l'AMF Assemblée Générale Investisseurs Rapport Financier Annuel Diagnostic Médical Eurobio Scientific
BRIEF published on 03/04/2025 at 20:08, 11 months 15 days ago Eurobio Scientific met fin à son contrat de liquidité Contrat De Liquidité TP ICAP Euronext Growth Diagnostic Médical Eurobio Scientific
BRIEF published on 03/04/2025 at 20:08, 11 months 15 days ago Eurobio Scientific terminates its liquidity contract Liquidity Contract TP ICAP Euronext Growth Medical Diagnosis Eurobio Scientific
PRESS RELEASE published on 03/04/2025 at 20:03, 11 months 15 days ago Eurobio Scientific : résiliation du contrat de liquidité Eurobio Scientific met fin au contrat de liquidité avec TP ICAP et communique sur ses moyens en compte. L'action est cotée sur Euronext Growth Paris Euronext Growth Paris Contrat De Liquidité Diagnostic Médical Fin Eurobio Scientific
Published on 02/20/2026 at 18:30, 13 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 2 hours 58 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 13 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 35 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 43 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 6 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 43 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 43 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 9 hours 15 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 15 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
